A detailed history of Fidelis Capital Partners, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 1,009 shares of BDX stock, worth $230,173. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,009
Previous 974 3.59%
Holding current value
$230,173
Previous $227 Million 7.11%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$221.47 - $242.41 $7,751 - $8,484
35 Added 3.59%
1,009 $243 Million
Q2 2024

Aug 13, 2024

SELL
$225.07 - $246.17 $26,558 - $29,048
-118 Reduced 10.81%
974 $227 Million
Q1 2024

May 03, 2024

SELL
$233.45 - $247.73 $3,034 - $3,220
-13 Reduced 1.18%
1,092 $270 Million
Q1 2024

May 01, 2024

SELL
$233.45 - $247.73 $26,613 - $28,241
-114 Reduced 9.35%
1,105 $246 Million
Q4 2023

Jan 31, 2024

BUY
$232.24 - $267.23 $283,100 - $325,753
1,219 New
1,219 $297 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Fidelis Capital Partners, LLC Portfolio

Follow Fidelis Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fidelis Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fidelis Capital Partners, LLC with notifications on news.